|
gptkbp:instanceOf
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:Pfizer
2002
|
|
gptkbp:dissolved
|
1995
|
|
gptkbp:employees
|
10,000 (1995)
|
|
gptkbp:founded
|
1886
|
|
gptkbp:founder
|
gptkb:William_E._Upjohn
|
|
gptkbp:headquarters
|
gptkb:Kalamazoo,_Michigan
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Upjohn Company
|
|
gptkbp:industry
|
pharmaceuticals
|
|
gptkbp:keyPeople
|
gptkb:William_E._Upjohn
gptkb:John_W._Upjohn
|
|
gptkbp:location
|
gptkb:United_States
|
|
gptkbp:previouslyKnownAs
|
Upjohn_Company_of_Kalamazoo
|
|
gptkbp:products
|
gptkb:Lisdexamfetamine
gptkb:Buprenorphine
gptkb:Xalatan
gptkb:Atripla
gptkb:Rogaine
gptkb:Lantus
gptkb:Avandia
gptkb:Zyvox
gptkb:Pristiq
gptkb:Truvada
gptkb:Bextra
gptkb:Strattera
Naloxone
Cymbalta
Duloxetine
Actos
Methylphenidate
Fentanyl
Lipitor
Viagra
Celebrex
Lyrica
Paxil
Procrit
Effexor
Clonidine
Milnacipran
Venlafaxine
Zoloft
Desvenlafaxine
Abilify
Seroquel
Risperdal
Gabapentin
Oxycodone
Pregabalin
Atomoxetine
Dexmethylphenidate
Methadone
Naltrexone
|
|
gptkbp:revenue
|
$1.5 billion (1995)
|
|
gptkbp:subsidiary
|
gptkb:Pfizer_Inc.
|
|
gptkbp:successor
|
gptkb:Pharmacia_Corporation
|
|
gptkbp:type
|
public company
|
|
gptkbp:website
|
www.upjohn.com
|